Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets (Parenthetical)

v3.20.1
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Mar. 31, 2020
Dec. 31, 2019
Restricted cash $ 34,090 $ 49,637
Notes receivable, net $ 429,993 $ 448,568
Common Stock, par value $ 0.01 $ 0.01
Common stock, shares authorized 100,000,000 100,000,000
Common stock, shares issued 72,484,293 74,362,693
Common stock, shares outstanding 72,484,293 74,362,693
Variable Interest Entity, Primary Beneficiary [Member]    
Restricted cash $ 17,456 $ 22,534
Notes receivable, net $ 288,435 $ 292,590